Mount Sinai-National Jewish Respiratory Institute212-241-5656
View location details
Book an Appointment
About Me
Clinical Focus
Education & Certifications
Awards
Research
Locations
Insurance
Publications
Patient Experience RatingPatient Experience Star Ratings and Comments
Industry Relationships
About Me
After completing her pulmonary fellowship at Mount Sinai School of Medicine and The Mount Sinai Medical Center, Dr. Padilla pursued her studies in lung transplantation by attending the programs at Toronto General Hospital and Stanford University. She was the co-founder of the program at The Mount Sinai Hospital in New York City. During her fellowship training, Dr. Padilla conducted research in pathology, developing models of pulmonary diseases under the mentorship of Dr. Jerome Kleinerman. She also participated in clinical research in Sarcoidosis and Interstitial Lung Diseases. She is a United Network for Organ Sharing (UNOS) certified transplant pulmonologist and a member of the International Society of Heart and Lung Transplantation (ISHLT). She served on the editorial and scientific advisory boards of the World Association of Sarcoidsosis and Other Granulomatous Diseases (WASOG). Dr. Padilla is a committee member of the Interstitial Lung Disease Network of the American College of Chest Physicians, and is also a steering committee member of the Pulmonary Fibrosis Indentification: Lessons for Optimizing Treatment (PILOT). She serves on the medical advisory boards of the Coalition for Pulmonary Fibrosis, the Sarcoidosis Research Foundation, the Hermansky Pudlak Syndrome Network, and the Scleroderma Foundation, Tri-State Chapter. She is a graduate of the Executive Leadership of American Medicine (ELAM) program.
Dr. Padilla is board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine. She is the Director of the Interstitial Lung Disease Program for the Mount Sinai – National Jewish Health Respiratory Institute. She is also involved in the Sarcoidosis Service and the adult Cystic Fibrosis program. She is a consultant to other transplant programs at our institution, and is also the principal investigator of clinical research projects. Dr. Padilla specializes in the treatment of diffuse interstitial lung diseases, including idiopathic interstital pneumonia, acute interstital pneumonia, lymphocytic interstital pneumonia, non-specific interstital pneumonia, organizing pneumonia, bronchiollitis obliterans, and hypersensitivity pneumonia. She also specializes in lung diseases associated with rheumatologic disorders, such as rheumatoid arthritis, dermatomyositis, mixed connective tissue disease, and systemic lupus erythematosus. In addition, she also treats drug-induced lung disease, mycobacterial lung disease, Langerhans cell hystiocytosis,lymphangioleimyomatosis, pulmonary vasculitis, alveolar hemorrhage, and pulmonary alveolar proteinosis.
Language
English, Spanish
Position
PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine, PROFESSOR | Artificial Intelligence and Human Health
Hospital Affiliations
The Mount Sinai Hospital
Show More
About Me
After completing her pulmonary fellowship at Mount Sinai School of Medicine and The Mount Sinai Medical Center, Dr. Padilla pursued her studies in lung transplantation by attending the programs at Toronto General Hospital and Stanford University. She was the co-founder of the program at The Mount Sinai Hospital in New York City. During her fellowship training, Dr. Padilla conducted research in pathology, developing models of pulmonary diseases under the mentorship of Dr. Jerome Kleinerman. She also participated in clinical research in Sarcoidosis and Interstitial Lung Diseases. She is a United Network for Organ Sharing (UNOS) certified transplant pulmonologist and a member of the International Society of Heart and Lung Transplantation (ISHLT). She served on the editorial and scientific advisory boards of the World Association of Sarcoidsosis and Other Granulomatous Diseases (WASOG). Dr. Padilla is a committee member of the Interstitial Lung Disease Network of the American College of Chest Physicians, and is also a steering committee member of the Pulmonary Fibrosis Indentification: Lessons for Optimizing Treatment (PILOT). She serves on the medical advisory boards of the Coalition for Pulmonary Fibrosis, the Sarcoidosis Research Foundation, the Hermansky Pudlak Syndrome Network, and the Scleroderma Foundation, Tri-State Chapter. She is a graduate of the Executive Leadership of American Medicine (ELAM) program.
Dr. Padilla is board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine. She is the Director of the Interstitial Lung Disease Program for the Mount Sinai – National Jewish Health Respiratory Institute. She is also involved in the Sarcoidosis Service and the adult Cystic Fibrosis program. She is a consultant to other transplant programs at our institution, and is also the principal investigator of clinical research projects. Dr. Padilla specializes in the treatment of diffuse interstitial lung diseases, including idiopathic interstital pneumonia, acute interstital pneumonia, lymphocytic interstital pneumonia, non-specific interstital pneumonia, organizing pneumonia, bronchiollitis obliterans, and hypersensitivity pneumonia. She also specializes in lung diseases associated with rheumatologic disorders, such as rheumatoid arthritis, dermatomyositis, mixed connective tissue disease, and systemic lupus erythematosus. In addition, she also treats drug-induced lung disease, mycobacterial lung disease, Langerhans cell hystiocytosis,lymphangioleimyomatosis, pulmonary vasculitis, alveolar hemorrhage, and pulmonary alveolar proteinosis.
Language
English, Spanish
Position
PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine, PROFESSOR | Artificial Intelligence and Human Health
The Dr Sidney Grossman Distinguished Humanitarian Award
Alumni Association, Mount Sinai School of Medicine
2001
Healthcare Foundation of New Jersey Humanism in Medicine Faculty Award\t
2001
2000 Physician of the Year Award
Nursing Department, MSMC
1999
Saul Horowitz Jr. Memorial Award
Mount Sinai School of Medicine
1996
Distinguished Service Award
The Samuel Bronfman Department of Medicine, MSMC
1989
Distinguished Teacher Award
The Samuel Bronfman Department of Medicine, MSMC
1987
Henry and Catherine Gaisman Fellowship
1982
Pulmonary Academic Award (NIH)\t
1980
American Lung Association Fellowship
1975
Dr. Alan Guttmacher Award
1974
Alpha Omega Alpha
1971
Max Som Scholarship
Research
Dr. Padilla's research interests include investigation of fibrogenesis and the various manifestations of this process in different diseases (Idiopathic Pulmonary Fibrosis, Sarcoidosis, Collagen Vascular associated pulmonary fibrosis, genetic associated pulmonary fibrosis, Hermansky Pudlak Syndrome, bronchiolitis obliterans among others). She conducts clinical investigations in the treatment and course of these diseases and participates in collaborative multicenter studies to advance the understanding and knowledge of these illnesses. She is the principal investigator of the INSPIRE trial investigating the safety and efficacy of Interferon gamma on the survival of patients with Idiopathic Pulmonary Fibrosis. Additional studies investigating early markers of interstitial lung disease, therapies for secondary pulmonary hypertension and the efficacy of certain agents on the pulmonary fibrosis associated with Hermansky Pudlak Syndrome, are in development.
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
Mount Sinai-National Jewish Respiratory Institute10 East 102nd Street, New York, NY, 10029
1199 SEIU
AETNA - Commercial
AETNA - Medicare
CIGNA Healthcare
Centivo
Elderplan
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Empire Blue Cross Blue Shield - Medicare
Fidelis Health Care
HealthFirst Medicare
Horizon NJ
Magnacare-Health Care
Medicare - NJ
Medicare - NY
Metroplus
Multiplan PHCS
Oscar
Oxford - Freedom and Liberty
Partners Health Plan
Senior Whole Health
United Health Care - Commercial
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
VillageCareMax
Mount Sinai-National Jewish Respiratory Institute10 East 102nd Street, New York, NY, 10029
1199 SEIU
AETNA - Commercial
AETNA - Medicare
CIGNA Healthcare
Centivo
Elderplan
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Empire Blue Cross Blue Shield - Medicare
Fidelis Health Care
HealthFirst Medicare
Horizon NJ
Magnacare-Health Care
Medicare - NJ
Medicare - NY
Metroplus
Multiplan PHCS
Oscar
Oxford - Freedom and Liberty
Partners Health Plan
Senior Whole Health
United Health Care - Commercial
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
VillageCareMax
1199 SEIU
AETNA - Commercial
AETNA - Medicare
CIGNA Healthcare
Centivo
Elderplan
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Show More
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.9 out of 5
Care Provider’s Concern
4.9 out of 5
Likelihood to Recommend Care Provider
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Padilla during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
United Therapeutics Corp.
Boehringer Ingelheim, Ltd.
Pfeizer Adjudicating Committee
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Show More
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Padilla during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
United Therapeutics Corp.
Boehringer Ingelheim, Ltd.
Pfeizer Adjudicating Committee
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.